150. Tsang RC, Fallat RW, Glueck CJ. Cholesterol at birth and age 1: comparison of normal and hypercholesterolemic neonates. Pediatrics 1974;53(4):458-470.
151. Kwiterovich PO, Jr., Levy RI, Fredrickson DS. Neonatal diagnosis of familial type-II hyperlipoproteinaemia. Lancet 1973;1(7795):118-121.
152. Andersen GE, Nielsen HG. Neonatal screening for hyperlipoproteinemia. Methods for direct estimation of cord serum VLDL + LDL. Clin Chim Acta 1976;66(1):29-41.
153. Van Biervliet JP, Vercaemst R, De Keersgieter W, Vinaimont N, Caster H, Rosseneu M. Evolution of lipoprotein patterns in newborns. Acta Paediatr Scand 1980;69(5):593-596.
154. Brewster TG, Waite DJ, Hudson GA. Quantitation of beta-lipoprotein in cord serum by rate nephelometric immunoassay: a potential screening test for familial hypercholesterolemia. Clin Chem 1982;28(5):1192-1196.
155. Wood WG, Schumacher M, Weigert S. (Apo)lipoprotein(a) concentrations at birth and in the first days and months of life—studies on the distribution of serum levels and the predictive value of measurements made at this time. Eur J Clin Chem Clin Biochem 1995;33(3):139-145.
156. Vladutiu GD, Glueck CJ, Schultz MT, McNeely S, Guthrie R. beta-Lipoprotein quantitation in cord blood spotted on filter paper: a screening test. Clin Chem 1980;26(9):1285-1290.
157. Wilcken DE, Blades BL, Dudman NP. A neonatal screening approach to the detection of familial hypercholesterolaemia and family-based coronary prevention. J Inherit Metab Dis 1988;11(Suppl 1):87-90.
158. Blades BL, Dudman NP, Wilcken DE. Screening for familial hypercholesterolemia in 5000 neonates: a recall study. Pediatr Res 1988;23(5):500-504.
159. Bangert SK, Eldridge PH, Peters TJ. Neonatal screening for familial hypercholesterolaemia by immunoturbidimetric assay of apolipoprotein B in dried blood spots. Clin Chim Acta 1992;213(1-3):95-101.
160. Van Biervliet JP, Vinaimont N, Caster H, Rosseneu M, Belpaire F. A screening procedure for dyslipoproteinemia in the newborn. Apoprotein quantitation on dried blood spots. Clin Chim Acta 1982;120(2):191-200.
161. Roseneu M, Van Biervliet JP. Screening and follow-up of infants with dyslipoproteinemia. Prog Clin Biol Res 1985;188:79-86.
162. Beeso J, Wong N, Ayling R, et al. Screening for hypercholesterolaemia in 10,000 neonates in a multi-ethnic population. Eur J Pediatr 1999;158(10):833-837.
163. Croyle RT, Sun YC, Louie DH. Psychological minimization of cholesterol test results: moderators of appraisal in college students and community residents. Health Psychol 1993;12(6):503-507.
164. Epstein LH, Kuller LH, Wing RR, Valoski A, McCurley J. The effect of weight control on lipid changes in obese children. Am J Dis Child 1989;143(4):454-457.
165. de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 2002;40(12):2117-2121.
166. McCrindle BW, Helden E, Cullen-Dean G, Conner WT. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia. Pediatr Res 2002;51(6):715-721.
167. de Jongh S, Vissers MN, Rol P, Bakker HD, Kastelein JJ, Stroes ES. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis 2003;26(4):343-351.
168. Gylling H, Siimes MA, Miettinen TA. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J Lipid Res 1995;36(8):1807-1812.
169. McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 2003;143(1):74-80.
170. Obarzanek E, Kimm SY, Barton BA, et al. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics 2001;107(2):256-264.
171. DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group. JAMA 1995;273(18):1429-1435.
172. Stein EA, Illingworth DR, Kwiterovich PO, Jr., et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 1999;281(2):137-144.
173. Knipscheer HC, Boelen CC, Kastelein JJ, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 1996;39(5):867-871.
174. Shannon BM, Tershakovec AM, Martel JK, Achterberg CL, Cortner JA. Reduction of elevated LDL-cholesterol levels of 4- to 10-year-old children through home-based dietary education. Pediatrics 1994;94(6):923-927.
175. Becque MD, Katch VL, Rocchini AP, Marks CR, Moorehead C. Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention. Pediatrics 1988;81(5):605-612.
176. McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr 1997;130(2):266-273.
177. Walter HJ, Hofman A, Connelly PA, Barrett LT, Kost KL. Primary prevention of chronic disease in childhood: changes in risk factors after one year of intervention. Am J Epidemiol 1985;122(5):772-781.
178. Amundsen AL, Ose L, Nenseter MS, Ntanios FY. Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. Am J Clin Nutr 2002;76(2):338-344.
179. Couture P, Brun LD, Szots F, et al. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1998;18(6):1007-1012.
180. Davidson MH, Dugan LD, Burns JH, Sugimoto D, Story K, Drennan K. A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study. Am J Clin Nutr 1996;63(1):96-102.
181. Dennison BA, Levine DM. Randomized, double-blind, placebo-controlled, two-period crossover clinical trial of psyllium fiber in children with hypercholesterolemia. J Pediatr 1993;123(1):24-29.
182. Engler MM, Engler MB, Malloy MJ, et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003;108(9):1059-1063.
183. Ferguson MA, Gutin B, Le NA, et al. Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int J Obes Relat Metab Disord 1999;23(8):889-895.
184. Lambert M, Lupien PJ, Gagne C, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics 1996;97(5):619-628.
185. Malloy MJ, Kane JP, Rowe JS. Familial hypercholesterolemia in children: treatment with p-aminosalicylic acid. Pediatrics 1978;61(3):365-372.
186. Tonstad S, Sivertsen M, Aksnes L, Ose L. Low dose colestipol in adolescents with familial hypercholesterolaemia. Arch Dis Child 1996;74(2):157-160.
187. Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 1996;129(1):42-49.
188. de Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 2002;106(17):2231-2237.
189. Kang HS, Gutin B, Barbeau P, et al. Physical training improves insulin resistance syndrome markers in obese adolescents. Med Sci Sports Exerc 2002;34(12):1920-1927.
190. Kuehl KS, Cockerham JT, Hitchings M, Slater D, Nixon G, Rifai N. Effective control of hypercholesterolemia in children with dietary interventions based in pediatric practice. Prev Med 1993;22(2):154-166.
191. Stallings VA, Cortner JA, Shannon BM, et al. Preliminary report of a home-based education program for dietary treatment of hypercholesterolemia in children. Am J Health Promot 1993;8(2):106-108.
192. Stergioulas A, Tripolitsioti A, Messinis D, Bouloukos A, Nounopoulos C. The effects of endurance training on selected coronary risk factors in children. Acta Paediatr 1998;87(4):401-404.
193. Wheeler KA, West RJ, Lloyd JK, Barley J. Double blind trial of bezafibrate in familial hypercholesterolaemia. Arch Dis Child 1985;60(1):34-37.
194. Williams CL, Bollella M, Spark A, Puder D. Soluble fiber enhances the hypocholesterolemic effect of the step I diet in childhood. J Am Coll Nutr 1995;14(3):251-257.
195. Boreham CA, Wallace WF, Nevill A. Training effects of accumulated daily stair-climbing exercise in previously sedentary young women. Prev Med 2000;30(4):277-281.
196. Gold K, Wong N, Tong A, et al. Serum apolipoprotein and lipid profile effects of an oat-bran-supplemented, low-fat diet in children with elevated serum cholesterol. Ann N Y Acad Sci 1991;623:429-431.
197. Linder CW, DuRant RH, Mahoney OM. The effect of physical conditioning on serum lipids and lipoproteins in white male adolescents. Med Sci Sports Exerc 1983;15(3):232-236.
198. Savage MP, Petratis MM, Thomson WH, Berg K, Smith JL, Sady SP. Exercise training effects on serum lipids of prepubescent boys and adult men. Med Sci Sports Exerc 1986;18(2):197-204.
199. Engler MM, Engler MB, Malloy M, et al. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Ther 2004;42(12):672-679.
200. McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 1998;152(11):1089-1094.
201. Engler MM, Engler MB, Malloy MJ, Paul SM, Kulkarni KR, Mietus-Snyder ML. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 2005;95(7):869-871.
202. Fernandes J, Dijkhuis-Stoffelsma R, Groot PH, Grose WF, Ambagtsheer JJ. The effect of a virtually cholesterol-free, high-linoleic-acid vegetarian diet on serum lipoproteins of children with familial hypercholesterolemia (type II-A). Acta Paediatr Scand 1981;70(5):677-682.
203. Hedman M, Neuvonen PJ, Neuvonen M, Antikainen M. Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia. Clin Pharmacol Ther 2003;74(2):178-185.
204. Dirisamer A, Hachemian N, Bucek RA, Wolf F, Reiter M, Widhalm K. The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation. Eur J Pediatr 2003;162(6):421-425.
205. Sinzinger H, O'Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol 2004;57(4):525-528.
206. de Jongh S, Kerckhoffs MC, Grootenhuis MA, Bakker HD, Heymans HS, Last BF. Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolaemia and their parents. Acta Paediatr 2003;92(9):1096-1101.
207. Ducobu J, Brasseur D, Chaudron JM, et al. Simvastatin use in children. Lancet 1992;339(8807):1488.
208. Stefanutti C, Lucani G, Vivenzio A, Di Giacomo S. Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood. Drugs Exp Clin Res 1999;25(1):23-28.
209. Curtis DM, Driscoll DJ, Goldman DH, Weidman WH. Loss of dental enamel in a patient taking cholestyramine. Mayo Clin Proc 1991;66(11):1131.
210. Farah JR, Kwiterovich PO, Neill CA. A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia. Adv Exp Med Biol 1977;82:212-215.
211. Farah JR, Kwiterovich PO, Jr., Neill CA. Dose-effect relation of cholestryamine in children and young adults with familial hypercholesterolaemia. Lancet 1977;1(8002):59-63.
212. Groot PH, Dijkhuis-Stoffelsma R, Grose WF, Ambagtsheer JJ, Fernandes J. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia. Acta Paediatr Scand 1983;72(1):81-85.
213. Hansen D, Michaelsen KF, Skovby F. Growth during treatment of familial hypercholesterolemia. Acta Paediatr 1992;81(12):1023-1025.
214. Harvengt C, Desager JP. Colestipol in familial type II hyperlipoproteinemia: a three-year trial. Clin Pharmacol Ther 1976;20(3):310-314.
215. Koletzko B, Kupke I, Wendel U. Treatment of hypercholesterolemia in children and adolescents. Acta Paediatr 1992;81(9):682-685.
216. Liacouras CA, Coates PM, Gallagher PR, Cortner JA. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia. J Pediatr 1993;122(3):477-482.
217. Schwarz KB, Goldstein PD, Witztum JL, Schonfeld G. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol. Pediatrics 1980;65(2):243-250.
218. Tonstad S, Ose L. Colestipol tablets in adolescents with familial hypercholesterolaemia. Acta Paediatr 1996;85(9):1080-1082.
219. Tonstad S, Refsum H, Ose L, Ueland PM. The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine. J Pediatr 1998;132(2):365-368.
220. West RJ, Lloyd JK. Use of cholestyramine in treatment of children with familial hypercholesterolaemia. Arch Dis Child 1973;48(5):370-374.
221. West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption. Gut 1975;16(2):93-98.
222. West RJ, Fosbrooke AS, Lloyd JK. Treatment of children with familial hypercholesterolaemia. Postgrad Med J 1975;51(8):suppl 82-87.
223. West RJ, Lloyd JK, Leonard JV. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine. Lancet 1980;2(8200):873-875.
224. Glueck CJ, Tsang RC, Fallat RW, Mellies M. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months. Pediatrics 1977;59(3):433-441.
225. Glueck CJ, Mellies MJ, Dine M, Perry T, Laskarzewski P. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia [retraction in Glueck CJ, Laskarzewski P, Meelies MJ, Perry T. Pediatrics 1987 Nov;80(5):766]. Pediatrics 1986;78(2):338-348.
226. Glueck CJ, Tsang RC, Fallat RW, Scheel D. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin. Pediatrics 1974;54(1):51-55.
227. Glueck CJ, Fallat R, Tsang R. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin. Pediatrics 1973;52(5):669-679.
228. Becker M, Staab D, Von Bergman K. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate. Pediatrics 1992;89(1):138-142.
229. Colletti RB, Neufeld EJ, Roff NK, McAuliffe TL, Baker AL, Newburger JW. Niacin treatment of hypercholesterolemia in children. Pediatrics 1993;92(1):78-82.
230. McDuffie JR, Calis KA, Uwaifo GI, et al. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res 2002;10(7):642-650.
231. Stein EA. Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis 1989;9(1 Suppl):I145-151.
232. Steinmetz J, Morin C, Panek E, Siest G, Drouin P. Biological variations in hyperlipidemic children and adolescents treated with fenofibrate. Clin Chim Acta 1981;112(1):43=53.
233. Copperman N, Schebendach J, Arden MR, Jacobson MS. Nutrient quality of fat- and cholesterol-modified diets of children with hyperlipidemia. Arch Pediatr Adol Med 1995;149(3):333-336.
234. Tonstad S, Novik TS, Vandvik IH. Psychosocial function during treatment for familial hypercholesterolemia. Pediatrics 1996;98(2 Pt 1):249-255.
235. Segall MM, Tamir I, Fosbrooke AS, Lloyd JK, Wolff OH. Effects of short-term high-carbohydrate feeding on serum triglyceride of children with familial hypercholesterolaemia. Arch Dis Child 1970;45(241):393-398.
236. Witschi JC, Singer M, Wu-Lee M, Stare FJ. Family cooperation and effectiveness in a cholesterol-lowering diet. J Am Diet Assoc 1978;72(4):384-389.
237. McKenzie J, Dixon LB, Smiciklas-Wright H, Mitchell D, Shannon B, Tershakovec A. Change in nutrient intakes, number of servings, and contributions of total fat from food groups in 4- to 10-year-old children enrolled in a nutrition education study. J Am Diet Assoc 1996;96(9):865-873.
238. Moreno LA, Sarria A, Lazaro A, Lasierra MP, Larrad L, Bueno M. Lymphocyte T subset counts in children with hypercholesterolemia receiving dietary therapy. Ann Nutr Metab 1998;42(5):261-265.
239. Sanchez-Bayle M, Gonzalez-Requejo A, Baeza J, et al. Diet therapy for hypercholesterolemia in children and adolescents. A follow-up. Arch Pediatr Adol Med 1994;148(1):28-32.
240. Rose V, Allen DM, Pearse RG, Chapell J. Primary hyperlipoproteinemia in childhood and adolescence: identification and treatment of persons at risk for premature atherosclerosis. CMAJ 1976;115(8):753-756, 779.
241. Lifshitz F, Moses N. Growth failure. A complication of dietary treatment of hypercholesterolemia. Am J Dis Child 1989;143(5):537-542.
242. Cetta F, Driscoll DJ, Lucas AR, et al. Growth patterns of hyperlipidemic children enrolled in a preventive cardiovascular health clinic. Clinical Pediatrics 1994;33(10):588-592.
243. Jacobson MS, Tomopoulos S, Williams CL, Arden MR, Deckelbaum RJ, Starc TJ. Normal growth in high-risk hyperlipidemic children and adolescents with dietary intervention. Prev Med 1998;27(6):775-780.
244. Lavigne JV, Brown KM, Gidding S, et al. A cholesterol-lowering diet does not produce adverse psychological effects in children: three-year results from the dietary intervention study in children. Health Psychol 1999;18(6):604-613.
245. Feoli-Fonseca JC, Levy E, Godard M, Lambert M. Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr 1998;133(3):417-423.
246. Sanchez-Bayle M, Soriano-Guillen L. Influence of dietary intervention on growth in children with hypercholesterolaemia. Acta Paediatr 2003;92(9):1043-1046.
247. Tershakovec AM, Jawad AF, Stallings VA, et al. Growth of hypercholesterolemic children completing physician-initiated low-fat dietary intervention. J Pediatr 1998;133(1):28-34.
248. Kaistha A, Deckelbaum RJ, Starc TJ, Couch SC. Overrestriction of dietary fat intake before formal nutritional counseling in children with hyperlipidemia. Arch Pediatr Adol Med 2001;155(11):1225-1230.
249. Pugliese MT, al. e. Parental health beliefs: a cause of non-organic failure to thrive. Pediatrics 1987;80(2):175-181.
250. Amundsen AL, Ntanios F, Put N, Ose L. Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. Eur J Clin Nutr 2004;58(12):1612-1620.
251. Becker M, Staab D, Von Bergmann K. Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr 1993;122(2):292-296.
252. Clarke JT, Cullen-Dean G, Regelink E, Chan L, Rose V. Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil. J Pediatr 1990;116(1):139-141.
253. Glassman M, Spark A, Berezin S, Schwartz S, Medow M, Newman LJ. Treatment of type IIa hyperlipidemia in childhood by a simplified American Heart Association diet and fiber supplementation. Am J Dis Child 1990;144:973-976.
254. Gulesserian T, Widhalm K. Effect of a rapeseed oil substituting diet on serum lipids and lipoproteins in children and adolescents with familial hypercholesterolemia. J Am Coll Nutr 2002;21(2):103-108.
255. Mietus-Snyder M, Malloy MJ. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy. J Pediatr 1998;133(1):35-40.
256. Sanchez-Bayle M, Gonzalez-Requejo A, Asensio-Anton J, Ruiz-Jarabo C, Fernandez-Ruiz ML, Baeza J. The effect of fiber supplementation on lipid profile in children with hypercholesterolemia. Clinical Pediatrics 2001;40(5):291-294.
257. Laurin D, Jacques H, Moorjani S, et al. Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia. Am J Clin Nutr 1991;54(1):98-103.
258. Schlierf G, Oster P, Heuck CC, Raetzer H, Schellenberg B. Sitosterol in juvenile type II hyperlipoproteinemia. Atherosclerosis 1978;30(4):245-248.
259. Zavoral JH, Hannan P, Fields DJ, et al. The hypolipidemic effect of locust bean gum food products in familial hypercholesterolemic adults and children. Am J Clin Nutr 1983;38(2):285-294.
260. Tolfrey K, Campbell IG, Batterham AM. Exercise training induced alterations in prepubertal children's lipid-lipoprotein profile. Med Sci Sports Exerc 1998;30(12):1684-1692.
261. Kavey RE, Kveselis DA, Gaum WE. Valvular and Pediatric Congenital Heart Disease. Am Heart J 1997;133(2).
262. Tighe DA, Ockene IS, Reed G, Nicolosi R. Calculated low density lipoprotein cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels < or =4.52 mmol/l: an analysis comparing the LipiDirect magnetic LDL assay with the Friedewald calculation. Clin Chim Acta 2006;365((1-2)):236-242.
263. Barter PF, Ballantyne C, Carmena R, et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten country panel. J Internal Med 2006;259:247-258.
264. Chan DC, Watts GF. Apolipoproteins as markers and managers of coronary risk. . QJM 2006;99(5):277-287.
265. Iannuzzi A, Licenziati MR, Acampora C, al. e. Increased carotid intima-media thickness and stiffness in obese children. Diabetes Care 2004;27(10):2506-2508.
266. Wiegman A, de Groot E, Hutten BA. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet 2004;363(9406):369-370.
267. Jarvisalo MJ, Lehtimaki T, Raitakari O. Determinants of arterial nitrate-mediated dilation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation 2004;109:2885-2889.
268. Rodenburg J, Vissers MN, Wiegman A, Trip MD, Bakker HD, Kastelein JJ. Familial hypercholesterolemia in children. Curr Opin Lipidol 2004;15(4):405-411.
1. Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology.
2. Oregon Evidence-based Practice Center, Department of Medicine.
3. Departments of Pediatrics and Molecular & Medical Genetics, Oregon Health & Science University, Portland, Oregon.
4. Women and Children's Health Research Center, Providence Health System, Portland, Oregon.
Corresponding Author: Elizabeth Haney, MD, Oregon Health and Science University, Mail Code L-475, 3181 SW Sam Jackson Park Road, Portland Oregon 97239, E-mail: haneye@ohsu.edu.
This document is in the public domain within the United States. For information on reprinting, contact Randie Siegel, Director, Division of Printing and Electronic Publishing, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850.
Requests for linking or to incorporate content in electronic resources should be sent to: http://info.ahrq.gov.
Support: This study was conducted by the Oregon Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality Contract Number 290-02-0024, Task Order Number #2, Rockville MD.
Source: Haney E, Huffman L, Bougatsos C, Freeman M, Steiner R, Nelson H. Screening and treatment for lipid disorders in children and adolescents: Systematic Evidence Review for the U.S. Preventive Services Task Force. Pediatrics 2007;120(1):e180-e214.
Current as of August 2007
Internet Citation:
Haney E, Huffman L, Bougatsos C, Freeman M, Steiner R, Nelson H. Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the U.S. Preventive Services Task Force. Originally in Pediatrics 2007;120(1):e180-e214. August 2007. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/uspstf07/chlipid/chlipidrev.htm
USPSTF
Topic Index
USPSTF Clinical Categories
U.S. Preventive Services Task
Force (USPSTF)
Clinical Information
AHRQ Home Page